Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 46-1773732 · Snapshot of IRS recognition, filing currency, financial health, and governance.
This organization recently began filing Form 990 and isn't in the IRS monthly Exempt Organizations file yet — it should appear in an upcoming BMF release. Verify Now may return Not Found until then.
To represent the voice of the emerging antimicrobials industry by building consensus on public policy solutions to tackle the commercial, regulatory and reimbursement challenges associated with the development of novel antibiotics. To engage regulators, policymakers, and lawmakers around the needs of the emerging antibiotics innovators by building support for revitalizing the pipeline of new antibiotics to fulfill a critical public health need.
Principal Officer
TOM Fagley
Total Revenue
$188K
FY2025
Total Expenses
$250K
FY2025
Net Assets
$11K
Program Ratio
71.9%
expenses on programs
Employees
0
Volunteers
0
Board Members
2
Voting
2
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.